Multidrug nanoformulations of vitamin D, anandamide and melatonin as a synergistic treatment for vascular inflammation

Virna Margarita Martín Giménez; Russel J. Reiter; Walter Manucha

doi:10.1016/j.drudis.2023.103539

Multidrug nanoformulations of vitamin D, anandamide and melatonin as a synergistic treatment for vascular inflammation

Virna Margarita Martín Giménez
, Russel J. Reiter
, Walter Manucha

Department of Cell Systems & Anatomy

Research output: Contribution to journal › Editorial › peer-review

3 Scopus citations

Original language	English (US)
Article number	103539
Journal	Drug Discovery Today
Volume	28
Issue number	6
DOIs	https://doi.org/10.1016/j.drudis.2023.103539
State	Published - Jun 2023

ASJC Scopus subject areas

Drug Discovery
Pharmacology

Access to Document

10.1016/j.drudis.2023.103539

Cite this

@article{35d248a0e4484c018594fe1f0bf00c46,

title = "Multidrug nanoformulations of vitamin D, anandamide and melatonin as a synergistic treatment for vascular inflammation",

author = "\{Mart{\'i}n Gim{\'e}nez\}, \{Virna Margarita\} and Reiter, \{Russel J.\} and Walter Manucha",

note = "Funding Information: The authors are grateful for financial support of their research to Secretar{\'i}a de Ciencia, T{\'e}cnica y Postgrado, Universidad Nacional de Cuyo, and from ANPCyT (Agencia Nacional de Promoci{\'o}n de la Ciencia y la Tecnolog{\'i}a, grant number PICT 2020 Serie A-4000, and PICTO Secuelas COVID-19), awarded to W. Manucha. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. ",

year = "2023",

month = jun,

doi = "10.1016/j.drudis.2023.103539",

language = "English (US)",

volume = "28",

journal = "Drug Discovery Today",

issn = "1359-6446",

publisher = "Elsevier Ltd",

number = "6",

}

TY - JOUR

T1 - Multidrug nanoformulations of vitamin D, anandamide and melatonin as a synergistic treatment for vascular inflammation

AU - Martín Giménez, Virna Margarita

AU - Reiter, Russel J.

AU - Manucha, Walter

N1 - Funding Information: The authors are grateful for financial support of their research to Secretaría de Ciencia, Técnica y Postgrado, Universidad Nacional de Cuyo, and from ANPCyT (Agencia Nacional de Promoción de la Ciencia y la Tecnología, grant number PICT 2020 Serie A-4000, and PICTO Secuelas COVID-19), awarded to W. Manucha. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

PY - 2023/6

Y1 - 2023/6

UR - https://www.scopus.com/pages/publications/85150466089

UR - https://www.scopus.com/pages/publications/85150466089#tab=citedBy

U2 - 10.1016/j.drudis.2023.103539

DO - 10.1016/j.drudis.2023.103539

M3 - Editorial

C2 - 36828191

AN - SCOPUS:85150466089

SN - 1359-6446

VL - 28

JO - Drug Discovery Today

JF - Drug Discovery Today

IS - 6

M1 - 103539

ER -

Multidrug nanoformulations of vitamin D, anandamide and melatonin as a synergistic treatment for vascular inflammation

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this